Alessia Castellino

10PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|Feb 27, 2026
Hypomethylating Agents and Venetoclax Based Triplets Targeting FLT3, IDH and KMT2A in Acute Myeloid Leukemia: Current Studies and Challenges of a Tailored Approach.

Elisa Santambrogio, Alessia Castellino, Ernesta Audisio

|Dec 30, 2025
Secondary Genetic Events and Their Relationship to TP53 Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL).

Maria Elena Carazzolo, Francesca Maria Quaglia, Antonino Aparo

|Jul 12, 2025
Next-Generation Therapies in Mantle Cell Lymphoma (MCL): The Evolving Landscape in Treatment of Relapse/Refractory After CAR-T Cells.

Elia Boccellato, Lorenzo Comba, Rita Tavarozzi

|Jun 11, 2025
Copanlisib in combination with rituximab and bendamustine for transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma patients: Results from the phase II multicentre FIL Copa-BR trial from Fondazione Italiana Linfomi (FIL).

Mattia Novo, Pio Manlio Mirko Frascione, Alessia Castellino

|Nov 25, 2023
Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical Practice.

Rita Tavarozzi, Giulia Zacchi, Daniela Pietrasanta

Pageof 2

Frequent Collaborators

2 joint publications

Alessandro Re

2 joint publications

Carlo Visco

2 joint publications

Francesco Piazza

2 joint publications

Annalisa Arcari